Search

everythinglearnresearchcommunity

for

Search:↓

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Box A of HMGB1 can improve stem cell function, aiding anti-aging therapy.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.